• Japanese AI startup secures $42.9M in series B financing biospectrumasia
    October 08, 2019
    The company intends to use the latest funding for the promotion of clinical trials, to further the development pipeline, acquisition of expert personnel, investment in equipment and overseas expansion.
PharmaSources Customer Service